CCL2-mediated monocytes regulate immune checkpoint blockade resistance in pancreatic cancer

被引：9
作者：
Li, Xiaocui [1 ]
He, Guijun [1 ]
Liu, Jican [2 ]
Yan, Meizhu [1 ]
Shen, Manru [1 ]
Xu, Linfang [1 ]
An, Min [1 ]
Huang, Jiying [1 ]
Gao, Zhenjun [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, QingPu Branch, 1158 Pk Rd E, Shanghai 201700, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Pathol, QingPu Branch, Shanghai 201700, Peoples R China
来源：
INTERNATIONAL IMMUNOPHARMACOLOGY | 2022年 / 106卷
关键词：
Pancreatic ductal adenocarcinoma; CCL2; Monocytes; Immunosuppression; Immunotherapy; ANTI-PD-L1; ANTIBODY; CHEMOATTRACTANT; IMMUNOTHERAPY; PROTEIN-1; CELLS;
D O I：
10.1016/j.intimp.2022.108598
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The immunosuppressive microenvironment of pancreatic ductal adenocarcinoma (PDAC) contributes to resistance to immune checkpoint blockade. C-C motif chemokine ligand 2 (CCL2) is believed to participate in pancreatic tumorigenesis, but its role in PDAC progression and resistance to immune checkpoint blockade remains unclear. We hypothesized that CCL2 contributes to the pancreatic immunosuppressive microenvironment. In this study, we found that CCL2 recruits monocytes to and decrease CD8+ T cell infiltration in pancreatic tumors. CCL2 inhibition and monocyte neutralization increased the sensitivity of PDAC to immune checkpoint blockade. The findings of our study suggest the potential of CCL2-mediated monocytes as a target for PDAC treatment.
引用
收藏
页数：8
相关论文
共 25 条
  • [11] Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
    Herbst, Roy S.
    Soria, Jean-Charles
    Kowanetz, Marcin
    Fine, Gregg D.
    Hamid, Omid
    Gordon, Michael S.
    Sosman, Jeffery A.
    McDermott, David F.
    Powderly, John D.
    Gettinger, Scott N.
    Kohrt, Holbrook E. K.
    Horn, Leora
    Lawrence, Donald P.
    Rost, Sandra
    Leabman, Maya
    Xiao, Yuanyuan
    Mokatrin, Ahmad
    Koeppen, Hartmut
    Hegde, Priti S.
    Mellman, Ira
    Chen, Daniel S.
    Hodi, F. Stephen
    [J]. NATURE, 2014, 515 (7528) : 563 - +
  • [12] Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
    Highfill, Steven L.
    Cui, Yongzhi
    Giles, Amber J.
    Smith, Jillian P.
    Zhang, Hua
    Morse, Elizabeth
    Kaplan, Rosandra N.
    Mackall, Crystal L.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (237)
  • [13] Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
    Kabacaoglu, Derya
    Ciecielski, Katrin J.
    Ruess, Dietrich A.
    Alguel, Hana
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [14] Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
    Kalbasi, Anusha
    Komar, Chad
    Tooker, Graham M.
    Liu, Mingen
    Lee, Jae W.
    Gladney, Whitney L.
    Ben-Josef, Edgar
    Beatty, Gregory L.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (01) : 137 - 148
  • [15] CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
    Kitamura, Takanori
    Qian, Bin-Zhi
    Soong, Daniel
    Cassetta, Luca
    Noy, Roy
    Sugano, Gael
    Kato, Yu
    Li, Jiufeng
    Pollard, Jeffrey W.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (07) : 1043 - 1059
  • [16] Immunotherapy for pancreatic cancer - Science driving clinical progress
    Laheru, D
    Jaffee, EM
    [J]. NATURE REVIEWS CANCER, 2005, 5 (06) : 459 - 467
  • [17] Monti P, 2003, CANCER RES, V63, P7451
  • [18] Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
    Patnaik, Amita
    Kang, S. Peter
    Rasco, Drew
    Papadopoulos, Kyriakos P.
    Elassaiss-Schaap, Jeroen
    Beeram, Muralidhar
    Drengler, Ronald
    Chen, Cong
    Smith, Lon
    Espino, Guillermo
    Gergich, Kevin
    Delgado, Liliana
    Daud, Adil
    Lindia, Jill A.
    Li, Xiaoyun Nicole
    Pierce, Robert H.
    Yearley, Jennifer H.
    Wu, Dianna
    Laterza, Omar
    Lehnert, Manfred
    Iannone, Robert
    Tolcher, Anthony W.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (19) : 4286 - 4293
  • [19] Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression
    Saleh, Reem
    Elkord, Eyad
    [J]. SEMINARS IN CANCER BIOLOGY, 2020, 65 : 13 - 27
  • [20] Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
    Sanford, Dominic E.
    Belt, Brian A.
    Panni, Roheena Z.
    Mayer, Allese
    Deshpande, Anjali D.
    Carpenter, Danielle
    Mitchem, Jonathan B.
    Plambeck-Suess, Stacey M.
    Worley, Lori A.
    Goetz, Brian D.
    Wang-Gillam, Andrea
    Eberlein, Timothy J.
    Denardo, David G.
    Goedegebuure, Simon Peter
    Linehan, David C.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (13) : 3404 - 3415
123